Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 23211433)

1.

Molecular alterations in meningiomas: association with clinical data.

Jaskolski DJ, Gresner SM, Zakrzewska M, Zawlik I, Piaskowski S, Sikorska B, Szybka M, Papierz W, Rieske P, Liberski PP.

Clin Neuropathol. 2013 Mar-Apr;32(2):114-21. doi: 10.5414/NP300527.

PMID:
23211433
2.

Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.

Mihaila D, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA; NABTT CNS Consortium.

Clin Cancer Res. 2003 Oct 1;9(12):4435-42.

3.

Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.

Rempel SA, Schwechheimer K, Davis RL, Cavenee WK, Rosenblum ML.

Cancer Res. 1993 May 15;53(10 Suppl):2386-92.

4.

Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.

Mihaila D, Jankowski M, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA; NABTT CNS Consortium.

Clin Cancer Res. 2003 Oct 1;9(12):4443-51.

5.

Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.

Menon AG, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW.

Oncogene. 1997 Feb 6;14(5):611-6.

6.

Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.

Lee JY, Finkelstein S, Hamilton RL, Rekha R, King JT Jr, Omalu B.

Neurosurgery. 2004 Nov;55(5):1163-73.

PMID:
15509323
7.

Molecular characteristics of meningiomas in a cohort of Indian patients: loss of heterozygosity analysis of chromosomes 22, 17, 14 and 10.

Asirvatham JR, Pai R, Chacko G, Nehru AG, John J, Chacko AG, Muliyil J.

Neurol India. 2013 Mar-Apr;61(2):138-43. doi: 10.4103/0028-3886.111119.

8.

Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?

Sayagués JM, Tabernero MD, Maíllo A, Espinosa A, Rasillo A, Díaz P, Ciudad J, López A, Merino M, Gonçalves JM, Santos-Briz A, Morales F, Orfao A.

J Mol Diagn. 2004 Nov;6(4):316-25.

9.

Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A.

Nakane Y, Natsume A, Wakabayashi T, Oi S, Ito M, Inao S, Saito K, Yoshida J.

J Neurosurg. 2007 Aug;107(2):398-404.

PMID:
17695396
10.

Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.

Lamszus K, Kluwe L, Matschke J, Meissner H, Laas R, Westphal M.

Cancer Genet Cytogenet. 1999 Apr 15;110(2):103-10.

PMID:
10214357
11.

Allelic loss at 1p is associated with tumor progression of meningiomas.

Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestaña A, Rey JA.

Genes Chromosomes Cancer. 1994 Apr;9(4):296-8.

PMID:
7519053
12.

NF2 status of meningiomas is associated with tumour localization and histology.

Kros J, de Greve K, van Tilborg A, Hop W, Pieterman H, Avezaat C, Lekanne Dit Deprez R, Zwarthoff E.

J Pathol. 2001 Jul;194(3):367-72.

PMID:
11439370
13.

Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.

Tse JY, Ng HK, Lau KM, Lo KW, Poon WS, Huang DP.

Hum Pathol. 1997 Jul;28(7):779-85.

PMID:
9224744
14.

Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression.

Lindblom A, Ruttledge M, Collins VP, Nordenskjöld M, Dumanski JP.

Int J Cancer. 1994 Feb 1;56(3):354-7.

PMID:
8314321
15.

NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.

Leone PE, Bello MJ, de Campos JM, Vaquero J, Sarasa JL, Pestaña A, Rey JA.

Oncogene. 1999 Apr 1;18(13):2231-9.

16.

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.

Am J Pathol. 2001 Aug;159(2):661-9.

17.

Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.

Sulman EP, Dumanski JP, White PS, Zhao H, Maris JM, Mathiesen T, Bruder C, Cnaan A, Brodeur GM.

Cancer Res. 1998 Aug 1;58(15):3226-30.

18.

Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.

Kim JH, Lee SH, Rhee CH, Park SY, Lee JH.

J Neurooncol. 1998 Nov;40(2):101-6.

PMID:
9892091
19.

DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.

Menghi F, Orzan FN, Eoli M, Farinotti M, Maderna E, Pisati F, Bianchessi D, Valletta L, Lodrini S, Galli G, Anghileri E, Pellegatta S, Pollo B, Finocchiaro G.

Oncologist. 2011;16(10):1440-50. doi: 10.1634/theoncologist.2010-0249. Epub 2011 Sep 23.

20.

BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.

Wozniak K, Piaskowski S, Gresner SM, Golanska E, Bieniek E, Bigoszewska K, Sikorska B, Szybka M, Kulczycka-Wojdala D, Zakrzewska M, Zawlik I, Papierz W, Stawski R, Jaskolski DJ, Och W, Sieruta M, Liberski PP, Rieske P.

Cancer Genet Cytogenet. 2008 May;183(1):14-20. doi: 10.1016/j.cancergencyto.2008.01.020.

PMID:
18474292
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk